Categories Other Industries

Arcadia Biosciences enters cannabis market, shares soar 68%

The latest addition to the burgeoning marijuana industry is agricultural innovation company Arcadia Biosciences (RKDA), which has set up a new unit to optimize the quality, yield and climate resiliency of cannabis. The new segment, Arcadia Specialty Genomics, will have Arcadia Chief Financial Officer Matt Plavan as its President.

Investors went gung-ho over the announcement, sending the stock up 68% during pre-market trading on Thursday.

Photo by Alex Person on Unsplash

Arcadia, whose primary operations involve developing and marketing proprietary breeding techniques for a slew of crops, said the weed unit would focus on the hemp market in the initial stages. The Davis, California-based firm added that its weed operations would be limited to regions that have legalized its use.

CEO Raj Ketkar said, “With this new operating unit, Arcadia Specialty Genomics, we are uniquely qualified as a proven crop improvement company equipped to address the legacy challenges facing a plant that until recently was largely grown unlawfully.”

READ: Aurora Cannabis to start production in Portugal

The company is hoping to develop novel cannabis varieties using its advanced screening and breeding tech called tilling and gene editing.

Matt Plavan said, “Our near-term focus will be acquiring federal and state licensure in key geographies to launch our research and pilot programs, for which we expect to begin operations in early 2019.”

Despite being a budding industry, the marijuana sector has been witnessing astounding growth over the past few years. Market research firm Brightfield Group estimates cannabis sales to touch $22 billion by 2022.

Meanwhile, according to The Hemp Business Journal, the hemp CBD market had totaled $190 million last year.

Also Read:  OPEC oil output tanks to four-year low


Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Levi Strauss (LEVI) Q1 profit beats estimates, withdraws annual outlook

Levi Strauss & Co. (NYSE: LEVI) reported a 4% increase in earnings for the first quarter of 2020 helped by lower income tax expenses despite a rise in operating expenses.

Vail Resorts (MTN) can reward investors once it gets past market crisis

The recent travel restrictions have taken a heavy toll on the tourism industry, leaving almost all destinations deserted. Vail Resorts Inc. (NYSE: MTN), a leading operator of mountain ski resorts,

The coming months will prove to be a testing time for Boeing (BA)

Shares of Boeing Co. (NYSE: BA) were up 13% in afternoon hours on Monday. The stock is down 63% from its 52-week high of $391. As the aviation industry suffers

One thought on “Arcadia Biosciences enters cannabis market, shares soar 68%

Comments are closed.